首页> 外国专利> New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents

New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents

机译:新多肽及其核酸,可用于治疗膀胱肿瘤和鉴定治疗药物

摘要

Polypeptide fragment sequences (I) are new and comprise 262 open reading frame amino acid sequences given in the specification, that are highly expressed in normal bladder tissue. Independent claims are also included for the following: (1) a nucleic acid (II) encoding (I) selected from 127 nucleic acid sequences given in the specification, or its allelic variants or antisense sequences; (2) bacterial or phage artificial chromosomes and cosmid clones containing functional genes, or the chromosome region containing them, corresponding to (II) for use as gene transfer vehicles; (3) antisense sequences of (II); (4) an expression cassette (III) comprising (II), or their fragments, plus control and regulatory sequences; (5) DNA fragments (IV) containing a gene isolated using (II); (6) host cells (V) containing (II) as a heterologous component; (7) recombinant production of polypeptides (I), or their fragments, by culturing (V); (8) an antibody (VI) directed against (I), or its fragments, encoded by (II); and (9) 263 partial polypeptide sequences, all defined in the specification, and sequences having at least 80% homology with them.
机译:多肽片段序列(I)是新的,包含规范中给出的262个开放阅读框氨基酸序列,这些序列在正常膀胱组织中高度表达。还包括以下方面的独立权利要求:(1)编码选自说明书中给出的127个核酸序列或其等位变体或反义序列的(I)的核酸(II); (2)对应于(II)的含有功能基因的细菌或噬菌体人工染色体和粘粒克隆,或含有它们的染色体区域,用作基因转移载体; (3)(II)的反义序列; (4)表达盒(III),其包含(II)或其片段,以及控制和调节序列; (5)DNA片段(IV),其含有用(II)分离的基因; (6)含有(II)作为异源成分的宿主细胞(V)。 (7)通过培养(V)重组生产多肽(I)或其片段; (8)(II)编码的针对(I)的抗体(VI)或其片段; (9)全部在说明书中定义的263个部分多肽序列,以及与它们具有至少80%同源性的序列。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号